4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-24-003229
Chief Scientific Officer gave up 1,080 shares (to pay taxes)
- Chief Scientific Officer acquired 3,680 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Or Yat Sun Chief Scientific Officer | 2024-02-12 | Grant or award | +3,680 | 374,375 | D | ||
| Or Yat Sun Chief Scientific Officer | 2024-02-12 | Shares withheld for taxes | −1,080 | $12.41 | $13,403 | 373,295 | D |
Loading xslF345X05/form4.xml…